Invention Grant
- Patent Title: Kinase modulators
-
Application No.: US15208984Application Date: 2016-07-13
-
Publication No.: US10538501B2Publication Date: 2020-01-21
- Inventor: Meyyappan Muthuppalaniappan , Srikant Viswanadha , Govindarajulu Babu , Swaroop K. Vakkalanka
- Applicant: Rhizen Pharmaceuticals SA
- Applicant Address: CH La Chaux-de-Fonds
- Assignee: Rhizen Pharmaceuticals SA
- Current Assignee: Rhizen Pharmaceuticals SA
- Current Assignee Address: CH La Chaux-de-Fonds
- Agency: Blank Rome LLP
- Priority: IN2690/CHE/2009 20091105; IN1429/CHE/2010 20100524
- Main IPC: C07D311/34
- IPC: C07D311/34 ; C07D519/00 ; C07D311/36 ; C07D405/06 ; C07D487/04 ; A61K31/437 ; A61K31/52 ; A61K31/5377 ; A61K45/06 ; C07D413/10 ; C07D413/14 ; C07D471/04 ; C07D473/34 ; A61K31/4178 ; A61K31/4184 ; A61K31/519 ; C07D473/38 ; A61K31/352 ; A61K31/522 ; C07D473/08 ; C07D473/40
Abstract:
The present invention provides PI3K protein kinase modulators of Formula (I) wherein R, R1,R2,L1, Cy1 and Cy2 are as disclosed herein, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.
Public/Granted literature
- US20160318890A1 NOVEL KINASE MODULATORS Public/Granted day:2016-11-03
Information query
